Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

407 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Advances in prognosis of chronic myeloid leukemia.
Baccarani M, Russo D, Fanin R, Zuffa E, Tura S. Baccarani M, et al. Among authors: fanin r. Haematologica. 1992 Sep-Oct;77(5):377-80. Haematologica. 1992. PMID: 1483586 No abstract available.
[Chronic myeloid leukemia: progress and prospects].
Baccarani M, Russo D, Fanin R. Baccarani M, et al. Among authors: fanin r. Haematologica. 1991 Jun;76 Suppl 3:40-5. Haematologica. 1991. PMID: 1752539 Review. Italian. No abstract available.
Treatment of Ph+ chronic myeloid leukemia by gamma interferon.
Russo D, Fanin R, Zuffa E, Gallizia C, Grazia Michieli M, Damiani D, Testoni N, Pecile V, Visani G, Colombini R, et al. Russo D, et al. Among authors: fanin r. Blut. 1989 Jul;59(1):15-20. doi: 10.1007/BF00320241. Blut. 1989. PMID: 2502210
[Update on the prognosis of chronic myeloid leukemia].
Baccarani M, Russo D, Zuffa E, Tassinari A, Fanin R, Zaccaria A. Baccarani M, et al. Among authors: fanin r. Haematologica. 1989 Oct;74(5 Suppl):358-67. Haematologica. 1989. PMID: 2512220 Review. Italian. No abstract available.
Neutralizing anti-interferon-alpha antibodies and response to treatment in patients with Ph+ chronic myeloid leukaemia sequentially treated with recombinant (alpha 2a) and lymphoblastoid interferon-alpha.
Russo D, Candoni A, Zuffa E, Minisini R, Silvestri F, Fanin R, Zaja F, Martinelli G, Tura S, Botta G, Baccarani M. Russo D, et al. Among authors: fanin r. Br J Haematol. 1996 Aug;94(2):300-5. doi: 10.1046/j.1365-2141.1996.d01-1790.x. Br J Haematol. 1996. PMID: 8759890
407 results